Tortugas Neuroscience Funding: $106M Raised, Series A (2026)
Tortugas Neuroscience is based in Framingham. It has raised $106M in total funding. Latest round: Series A.
Tortugas Neuroscience funding overview
Tortugas Neuroscience is based in Framingham. Tortugas Neuroscience has raised $106M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in April 2026. The round record for Tortugas Neuroscience runs through 2026; nothing later has been disclosed. Investors on record include Cure Ventures, The Column Group, AN Venture Partners. 3 distinct backers are named across the disclosed rounds.
Tortugas Neuroscience at a glance
Total raised
$106M
Latest round
Series A
Latest round date
April 2026
Headquarters
Framingham
Notable investors
Cure Ventures, The Column Group, AN Venture Partners
Frequently asked about Tortugas Neuroscience funding
How much has Tortugas Neuroscience raised?
Tortugas Neuroscience has raised $106M in total disclosed funding across the rounds on record.
Who has invested in Tortugas Neuroscience?
Cure Ventures, The Column Group, AN Venture Partners are named among the investors backing Tortugas Neuroscience.
What was the latest Tortugas Neuroscience funding round?
The most recent disclosed round is a Series A, announced in April 2026.
Where is Tortugas Neuroscience based?
Tortugas Neuroscience is based in Framingham.
When did Tortugas Neuroscience last raise?
The last disclosed Tortugas Neuroscience round closed in April 2026 at Series A.
Round data for Tortugas Neuroscience is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Framingham and backer lists below.
